UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020292
Receipt number R000023432
Scientific Title Multicenter retrospective study to validate the safety and efficacy of laparoscopic sleeve gastrectomy and laparoscopic sleeve gastrectomy + duodeno-jejunal bypass for morbid obesity
Date of disclosure of the study information 2016/01/01
Last modified on 2017/12/25 20:23:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter retrospective study to validate the safety and efficacy of laparoscopic sleeve gastrectomy and laparoscopic sleeve gastrectomy + duodeno-jejunal bypass for morbid obesity

Acronym

Multicenter retrospective study of laparoscopic sleeve gastrectomy and laparoscopic sleeve gastrectomy + duodeno-jejunal bypass

Scientific Title

Multicenter retrospective study to validate the safety and efficacy of laparoscopic sleeve gastrectomy and laparoscopic sleeve gastrectomy + duodeno-jejunal bypass for morbid obesity

Scientific Title:Acronym

Multicenter retrospective study of laparoscopic sleeve gastrectomy and laparoscopic sleeve gastrectomy + duodeno-jejunal bypass

Region

Japan


Condition

Condition

Morbid obesity

Classification by specialty

Gastrointestinal surgery Endocrine surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of Laparoscopic Sleeve Gastrectomy and Laparoscopic Sleeve Gastrectomy + Duodeno-Jejunal Bypass

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

To evaluate safety
Confirm postoperative complications within 30 post operative days

Key secondary outcomes

To evaluate efficacy
Weight loss and HbA1c at 12months after surgery


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Morbid obesity patients who underwent LSG or LSG/DJB from January 2005 to December 2015, satisfying following conditions

1, BMI 35Kg / m2 or more at first medical examination
2, Age: 18-65 years of age
3, Gender: unquestioned

Key exclusion criteria

Patients determined to be inappropriate as a test subject by investigators

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Naitoh

Organization

Tohoku University Hospital

Division name

Department of surgery

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN

TEL

022-717-7205

Email

naitot@surg1.med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Tanaka

Organization

Tohoku University Hospital

Division name

Department of surgery

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN

TEL

022-717-7205

Homepage URL


Email

n-tanaka@surg1.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 21 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2017 Year 01 Month 01 Day

Date of closure to data entry

2017 Year 03 Month 30 Day

Date trial data considered complete

2017 Year 04 Month 30 Day

Date analysis concluded

2017 Year 06 Month 30 Day


Other

Other related information

Multicenter retrospective study
Including criteria
Morbid obesity patients who underwent LSG or LSG/DJB from January 2005 to December 2015, satisfying following conditions

1, BMI 35Kg / m2 or more, or BMI 32Kg / m2 or more complicated with DM
2, Age: 18-65 years of age
3, Gender: unquestioned


Management information

Registered date

2015 Year 12 Month 21 Day

Last modified on

2017 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023432


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name